Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Blood Cancer Market Global Briefing 2017

Blood Cancer Market Global Briefing 2017

From $1,000.00

Including: Biological/Immunotherapy, Chemotherapy, Radiation Therapy, Targeted Therapy, And Stem Cell Transplantation.
Covering: Abbvie, Amgen, F. Hoffmann-La Roche, Bristol-Myers Squibb, Astra Zeneca


Clear selection
SKU: 2265. Category: .
Description

Blood cancer Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global blood cancer market.

Description

The Blood cancer Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The blood cancer market is one of the segments in the oncology drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the blood cancer market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the blood cancer market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the blood cancer market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Biological/immunotherapy, Chemotherapy, Radiation Therapy, Targeted Therapy, and Stem Cell Transplantation.

Companies Mentioned: Abbvie, Amgen, F. Hoffmann-La Roche, Bristol-Myers Squibb, Astra Zeneca.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Lung cancer Market Global Briefing 2017
Pancreatic cancer Market Global Briefing 2017
Breast cancer Market Global Briefing 2017
Prostate cancer Market Global Briefing 2017
Ovarian cancer Market Global Briefing 2017
Gastric Cancer Market Global Briefing 2017
Non-Small Cell Lung Cancer Market Global Briefing 2017
Brain Tumor Market Global Briefing 2017
Colorectal Cancer Market Global Briefing 2017
Thyroid cancer Market Global Briefing 2017
Bladder Cancer Market Global Briefing 2017
Kidney Cancer Market Global Briefing 2017
Skin cancer Market Global Briefing 2017
Cervical Cancer Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Blood cancer Market Characteristics
3. Blood cancer Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Blood cancer Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Blood cancer Market Geography Split
6. Blood cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
7. Blood cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
8. Blood cancer Market Segmentation
9. Blood cancer Competitive Landscape
Abbvie
Amgen
F. Hoffmann-La Roche
Bristol-Myers Squibb
Astra Zeneca
10. Key Mergers And Acquisitions In The Blood cancer Market
11. Blood cancer Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Blood cancer Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Blood cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Blood cancer Market, Split By Region, 2016, $ Billion
Table 4: Blood cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Table 5: Blood cancer Market As A Proportion of Oncology Drugs Market, 2016, By Country
Table 6: Global Blood cancer Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Blood cancer Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Blood cancer Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Blood cancer Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Blood cancer Market, Split By Region, 2016, $ Billion
Figure 4: Blood cancer Market As A Proportion of Oncology Drugs Market, 2016, By Region
Figure 5: Blood cancer Market As A Proportion of Oncology Drugs Market, 2020, By Country
Figure 6: Global Blood cancer Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Blood cancer Market, Split By Segments, 2016, $ Billion
Executive Summary
The blood cancer drugs market covers drugs that treat cancer that affects blood and blood components. These indications include leukemia (acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, hairy cell leukemia, mast cell leukemia, and meningeal leukemia), non-hodgkin lymphoma, hodgkin lymphoma, multiple myeloma. Based on therapeutic type, the market is segmented into five segments: biological/immunotherapy, chemotherapy, radiation therapy, targeted therapy, and stem cell transplantation. Some of the major drugs in this market are Rituximab (Rituxan/MabThera); Imatinib (Gleevec); obinutuzumab (Gazya); and ibrutinib (Imbruvica).

The global blood cancer market was estimated to be around $26.3 billion as of 2016. The global blood cancer made up around 22% of the overall oncology drugs market in 2016. The blood cancer market was the largest market in the global oncology drugs market in 2016.

Strategic Partnerships
Partnerships and agreements by major competitors in this market to develop new blood cancer treatment drugs and also to expand its business operations is one of the major trends in this market. For instance, in August 2016, MEI Pharma collaborated with Helsinn to develop and market Pracinostat, HDAC (the class of enzyme knows as Histone deacetylase) inhibitor. It is used in the treatment of acute myeloid leukemia and myelodysplastic syndrome.

R&D of Blood Cancer Drugs
Continous technological innovation by the major competitors to launch new products is a major trend in this market. For instance, in April 2017, Novartis received FDA approval for its Rydapt for two indications, the first indication is for the treatment of acute myeloid leukemia and the second indication is for the treatment of advanced systemic mastocytosis. In June 2017, Pfizer received approval from European Comission for its ESPONSA (inotuzumab ozogamicin) as monotherapy for the treatment of acute lymphoblastic leukemia.
Get Customized Report
Please fill in your details. Our team will get back to you